ZLMT-72

ZLMT-72 is an orally active dual CDK2 and CDK9 inhibitor with IC50s of 0.741 nM and 1.03 nM, respectively. ZLMT-72 shows good selectivity in kinase profiling andcholinesterase inhibition activity. ZLMT-72 has strong antiproliferative effects in the colorectal cancer (CRC) cell line HCT116 (GI50 < 0.1 nM). ZLMT-72 induces apoptosis by inhibiting thephosphorylation of retinoblastoma and RNA polymerase II, resulting in downregulation of antiapoptotic proteins (Mcl-1 and XIAP). ZLMT-72 can be used for the study of colorectal cancer (CRC).

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Fòrmula: C29H32FN5O
  • Peso molecular:485.60
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas CDK

More

Ver todos los productos específicos de isoformas DNA/RNA Synthesis

More

Ver todos los productos específicos de isoformas Bcl-2 Family

More

Ver todos los productos específicos de isoformas IAP

More
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00